ArticleIn vivo (Athens, Greece)

Baseline Troponin Level and Cardiac Toxicity in HER2-positive Early Breast Cancer Patients Receiving Trastuzumab.

Maria Laura Canale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.